𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists

✍ Scribed by Karina L. Bienfait; Matthew Menza; Margery H. Mark; Roseanne D. Dobkin


Book ID
116675356
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
111 KB
Volume
17
Category
Article
ISSN
0967-5868

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Valvular heart disease in Parkinson's di
✍ Ji-Youn Kim; Eun Joo Chung; Seung Woo Park; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Valvular heart disease, associated with ergot derivative dopamine agonists, has been reported in patients with Parkinson's disease (PD). There are few comparative studies on the frequency, severity, and dose dependency of valvular disease associated with ergot derivatives. We analyzed these factors

The risk of valvular regurgitation in pa
✍ Vibeke Guldbrand Rasmussen; Karen Østergaard; Erik Dupont; Steen Hvitfeldt Pouls 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objectives: Several observational studies suggest an association between treatment with ergoline‐derived dopamine agonists and valvular regurgitation. In this article, we present an overview of the literature and conduct a meta‐analysis. ## Methods: Observational studies addressin

Meta-analysis of heart valve abnormaliti
✍ Gregor Simonis; Joerg T. Fuhrmann; Ruth H. Strasser 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract Valvular heart disease in patients being treated with ergot‐derivative dopamine agonists (Ergot‐DA) for Parkinson's disease has been reported to occur as a consequence of serotonine receptor stimulation. Goal of this analysis was to estimate the incidence of those changes from recently